No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
XRAY240621C25000
- 0.80
- 0.000.00%
15min DelayTrading Jun 18 15:56 ET
0.00High0.00Low
0.00Open0.80Pre Close0 Volume9 Open Interest25.00Strike Price0.00Turnover49.25%IV0.55%PremiumJun 21, 2024Expiry Date0.66Intrinsic Value100Multiplier1DDays to Expiry0.14Extrinsic Value100Contract SizeAmericanOptions Type0.7485Delta0.3774Gamma32.08Leverage Ratio-0.0920Theta0.0008Rho24.01Eff Leverage0.0055Vega
Intraday
- 5D
- Daily
No Data
News
Invisible Orthodontics Market Analysis 2014-2030 Featuring Strategic Profiles of 47 Competitors Including 3M Company, Align Technology, American Orthodontics, ClearCorrect, Danaher Corporation, Dentsply Sirona
Should You Investigate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) At US$26.11?
Shareholders in DENTSPLY SIRONA (NASDAQ:XRAY) Have Lost 57%, as Stock Drops 3.9% This Past Week
Investing in stocks inevitably means buying into some companies that perform poorly. Long term DENTSPLY SIRONA Inc. (NASDAQ:XRAY) shareholders know that all too well, since the share price is down co
Express News | Dentsply Sirona Cancels Its Participation In The Goldman Sachs 45Th Annual Global Healthcare Conference Citing Weather-Related Flight Disruptions
Dentsply Sirona: Canceling Participation in Goldman Sachs Annual Global Healthcare Conference Due to Weather-Related Flight Disruptions >XRAY
Dentsply Sirona: Canceling Participation in Goldman Sachs Annual Global Healthcare Conference Due to Weather-Related Flight Disruptions >XRAY
Express News | Dentsply Sirona Provides Update on June Investor Conference Participation
Comments
The company's low growth and lack of profits have led to a stock price drop. A revenue growth acceleration might boost the share price. However, the real benefit for shareholders will be if the company starts making profits. Despite recent gains, the returns over the last three years have been disappointing.
DENTSPLY SIRONA (NASDAQ:XRAY) Shareholders Have Endured a 32% Loss From Investing in the Stock Three Years Ago 1
DENTSPLY SIRONA's decreasing capital employment and flat returns are concerning. The stock's decline may reflect investor pessimism about these trends. The analysis does not see the traits of a multi-bagger in this stock.
DENTSPLY SIRONA's decision to pay a dividend amidst a reported loss is unsettling. It's not an ideal choice for long-term buy and hold investors.
1
Investors predict limited future growth for the company, reflected by its low P/S ratio. The pessimism around its revenue prospect contributes to its undervalued stock.
DENTSPLY SIRONA, currently undervalued with steady price trends, could make a solid investment. Despite modest growth projections, aspects like capital structure and management track record could be behind its undervaluation.
Read more